Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and neck.
暂无分享,去创建一个
K. Ang | M. Suntharalingam | Q. Zhang | K. Sultanem | A. Cmelak | Q. Le | M. Parliament | G. Shenouda | A. Lin | M. Machtay | M. Rotman | D. Hershock | A. Nabid | Susanna Hong | S. Shehata
[1] M. Todaro,et al. Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy. , 2013, Cancer research.
[2] M. Suntharalingam,et al. Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). , 2007, International journal of radiation oncology, biology, physics.
[3] Wilson Roa,et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Aapro,et al. Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia. , 2007, European journal of cancer.
[5] M. Pepe,et al. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Kevin Wei,et al. VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis , 2006, Nature Medicine.
[7] Michael Höckel,et al. Impact of Hemoglobin Levels on Tumor Oxygenation: the Higher, the Better? , 2006, Strahlentherapie und Onkologie.
[8] B. Zackrisson,et al. Recombinant erythropoietin β enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma , 2006, Acta oto-laryngologica.
[9] J. Baselga,et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Grandis,et al. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma , 2005, Oncogene.
[11] M. Arcasoy,et al. Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] T. Chow,et al. Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. , 2004, Molecular cancer therapeutics.
[13] C. Koch,et al. Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells. , 2004, Cancer letters.
[14] T. Chow,et al. Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma , 2004, International Journal of Gynecologic Cancer.
[15] M. Rose,et al. Erythropoietin to treat head and neck cancer patients with anemia undergoing radiotherapy. , 2004, Current hematology reports.
[16] Ahmed Mohyeldin,et al. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. , 2003, The American journal of pathology.
[17] Yoshiko Yasuda,et al. Erythropoietin regulates tumour growth of human malignancies. , 2003, Carcinogenesis.
[18] Y. Brandberg,et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy , 2003, Cancer.
[19] G. Demetri,et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy , 2002, Cancer.
[20] G. Acs,et al. Erythropoietin and erythropoietin receptor expression in human cancer. , 2001, Cancer research.
[21] C. Westenfelder,et al. Erythropoietin stimulates proliferation of human renal carcinoma cells. , 2000, Kidney international.
[22] C. Grau,et al. Significance of Hemoglobin Concentration for Treatment Outcome , 2000 .
[23] H. Goldschmidt,et al. Recombinant human erythropoietin in the treatment of cancer. , 2000, Antibiotics and chemotherapy.
[24] D. Ribatti,et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. , 1999, Blood.
[25] Epoetin alfa improves quality of life , 1998 .
[26] J. Kugler,et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. , 1993, Journal of the National Cancer Institute.
[27] R. Abels. Recombinant human erythropoietin in the treatment of the anaemia of cancer. , 1992, Acta haematologica.